Serum iron concentration, but not hemoglobin, correlates with TIMI risk score and 6-month left ventricular performance after primary angioplasty for acute myocardial infarction

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Huang, Ching Hui ^a,b   Chang, Chia Chu ^a,c   Kuo, Chen Ling ^a   Huang, Ching Shan ^a   Chiu, Tzai Wen ^b   Lin, Chih Sheng ^b   Liu, Chin San ^a,d  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; HEMOGLOBIN; INTERLEUKIN 6; IRON; TROPONIN I; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE FUNCTION AND CHARACTERISTICS; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE PERFORMANCE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; RED CELL DISTRIBUTION WIDTH; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOLYSIS IN MYOCARDIAL INFARCTION RISK SCORE; TRANSLUMINAL CORONARY ANGIOPLASTY; ACUTE CORONARY SYNDROME; AGED; BLOOD; CLINICAL TRIAL; HEART STROKE VOLUME; HEART VENTRICLE; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOPLASTY, BALLOON, CORONARY; BIOMARKERS; FEMALE; HEART VENTRICLES; HEMOGLOBINS; HUMANS; IRON; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; STROKE VOLUME;

EID: 84905495706     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104495     Document Type: Article

References (40)

1. Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P (2013) Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. European heart journal 34: 816-829.
2. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, et al. (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. New England Journal of Medicine 361: 2436-2448.
3. Maeder MT, Khammy O, dos Remedios C, Kaye DM (2011) Myocardial and Systemic Iron Depletion in Heart FailureImplications for Anemia Accompanying Heart Failure. Journal of the American College of Cardiology 58: 474-480.
4. McMurray J, Ponikowski P (2011) Heart FailureNot Enough Pump Iron? Journal of the American College of Cardiology 58: 481-482.
5. Simel DL, DeLong ER, Feussner JR, Weinberg JB, Crawford J (1988) Erythrocyte anisocytosis: visual inspection of blood films vs automated analysis of red blood cell distribution width. Archives of internal medicine 148: 822-824.
6. Uyarel H, Ergelen M, Cicek G, Kaya MG, Ayhan E, et al. (2011) Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coronary artery disease 22: 138-144.
7. Dabbah S, Hammerman H, Markiewicz W, Aronson D (2010) Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. The American journal of cardiology 105: 312-317.
8. Ilhan E, Güvenç TS, Altay S, Çagdas M, Çalik AN, et al. (2012) Predictive value of red cell distribution width in intrahospital mortality and postintervention thrombolysis in myocardial infarction flow in patients with acute anterior myocardial infarction. Coronary artery disease 23: 450-454.
9. Rines AK, Ardehali H (2013) Transition metals and mitochondrial metabolism in the heart. Journal of molecular and cellular cardiology 55: 50-57.
10. Anker SD, Voors A, Okonko D, Clark AL, James MK, et al. (2009) Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial. European heart journal 30: 1331-1339.
11. Aronson D, Suleiman M, Agmon Y, Suleiman A, Blich M, et al. (2007) Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. European heart journal 28: 1289-1296. (Pubitemid 47355975)
12. Nikolsky E, Aymong ED, Halkin A, Grines CL, Cox DA, et al. (2004) Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary interventionAnalysis from the controlled abciximab and device investigation to lower late angioplasty complications (cadillac) trial. Journal of the American College of Cardiology 44: 547-553. (Pubitemid 39078177)
13. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, et al. (2003) Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction the Framingham Heart Study. Circulation 107: 1486-1491. (Pubitemid 36378485)
14. Tan J, Hua Q, Li J, Fan Z (2009) Prognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction. Heart and vessels 24: 329-334.
15. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, et al. (2000) TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102: 2031-2037.
16. Wiviott SD, Morrow DA, Frederick PD, Giugliano RP, Gibson CM, et al. (2004) Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and-4A simple index that predicts mortality in ST-segment elevation myocardial infarction. Journal of the American College of Cardiology 44: 783-789. (Pubitemid 39099573)
17. Thygesen K, Alpert JS, White HD (2007) Universal definition of myocardial infarction. Journal of the American College of Cardiology 50: 2173-2195. (Pubitemid 350123680)
18. Ndrepepa G, Mehilli J, Martinoff S, Schwaiger M, Schömig A, et al. (2007) Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction. Journal of the American College of Cardiology 50: 149-156. (Pubitemid 47002186)
19. Investigators GA (1993) The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl j Med 329: 1615-1622.
20. Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, et al. (2000) Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101: 125-130. (Pubitemid 30044249)
21. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, et al. (1990) Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 82: 1193-1202.
22. Schiller NB, Shah P, Crawford M, DeMaria A, Devereux R, et al. (1988) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography 2: 358-367.
23. Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA (2002) Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Journal of the American Society of Echocardiography 15: 167-184.
24. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, et al. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography 18: 1440-1463. (Pubitemid 41821197)
25. Feigenbaum H (1990) Role of echocardiography in acute myocardial infarction. The American journal of cardiology 66: H17-H22.
26. Lenth RV (2010) Java applets for power and sample size (computer software) 2006-9. Available: http://www.stat.uiowa.edu/~rlenth/Power. Accessed 2014 Jun 08.
27. Chan W, Taylor AJ, Ellims AH, Lefkovits L, Wong C, et al. (2012) Effect of Iron Chelation on Myocardial Infarct Size and Oxidative Stress in ST-Elevation-Myocardial Infarction. Circulation: Cardiovascular Interventions 5: 270-278.
28. Lee S-D, Huang C-Y, Shu W-T, Chen T-H, Lin JA, et al. (2006) Proinflammatory states and IGF-I level in ischemic heart disease with low or high serum iron. Clinica chimica acta 370: 50-56. (Pubitemid 44096943)
29. Muñoz M, García-Erce JA, Remacha ÁF (2011) Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis. Journal of clinical pathology 64: 281-286.
30. Zeben D, Bieger R, Wermeskerken RK, Castel A, Hermans J (1990) Evaluation of microcytosis using serum ferritin and red blood cell distribution width. European journal of haematology 44: 106-109. (Pubitemid 20172162)
31. Kell DB (2009) Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC medical genomics 2: 2.
32. Hower V, Mendes P, Torti FM, Laubenbacher R, Akman S, et al. (2009) A general map of iron metabolism and tissue-specific subnetworks. Molecular bioSystems 5: 422-443.
33. Cairo G, Bernuzzi F, Recalcati S (2006) A precious metal: Iron, an essential nutrient for all cells. Genes & nutrition 1: 25-39.
34. Beard JL (2001) Iron biology in immune function, muscle metabolism and neuronal functioning. The Journal of Nutrition 131: 568S-580S.
35. Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105: 1135-1143. (Pubitemid 34212626)
36. Karpiński L, Płaksej R, Kosmala W, Witkowska M (2008) Serum levels of interleukin-6, interleukin-10 and C-reactive protein in relation to left ventricular function in patients with myocardial infarction treated with primary angioplasty. Kardiologia polska 66: 1279-1285.
37. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, et al. (2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. Journal of Clinical Investigation 113: 1271-1276. (Pubitemid 39069926)
38. Simonis G, Mueller K, Schwarz P, Wiedemann S, Adler G, et al. (2010) The iron-regulatory peptide hepcidin is upregulated in the ischemic and in the remote myocardium after myocardial infarction. Peptides 31: 1786-1790.
39. Suzuki H, Toba K, Kato K, Ozawa T, Tomosugi N, et al. (2009) Serum hepcidin-20 is elevated during the acute phase of myocardial infarction. Tohoku journal of experimental medicine 218.
40. Gabriel AS, Martinsson A, Wretlind B, Ahnve S (2004) IL-6 levels in acute and post myocardial infarction: their relation to CRP levels, infarction size, left ventricular systolic function, and heart failure. European Journal of Internal Medicine 15: 523-528. (Pubitemid 40164483)